Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer

D. P. Petrylak, R. Macarthur, J. O'Connor, G. Shelton, A. Weitzman, T. Judge, C. England-Owen, N. Zuech, C. Pfaff, J. Newhouse, E. Bagiella, D. Hetjan, I. Sawczuk, M. Benson, C. Olsson

Research output: Contribution to journalReview articlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences